US Stock MarketDetailed Quotes
MURA Mural Oncology
- 3.180
- +0.040+1.27%
Close Dec 20 16:00 ET
- 3.160
- -0.020-0.63%
Post 20:01 ET
54.25MMarket Cap-0.35P/E (TTM)
3.300High3.100Low207.56KVolume3.300Open3.140Pre Close660.96KTurnover1.64%Turnover RatioLossP/E (Static)17.06MShares6.25052wk High0.31P/B40.37MFloat Cap2.87052wk Low--Dividend TTM12.69MShs Float57.200Historical High--Div YieldTTM6.37%Amplitude2.870Historical Low3.184Avg Price1Lot Size
Mural Oncology Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -26.37%34.1M | -27.47%34.28M | -22.93%34.03M | 6.12%196.24M | 23.54%58.51M | -6.06%46.31M | 47.26M | 44.16M | 5.45%184.92M | 47.36M |
| Selling and administrative expenses | 9.30%6.51M | 42.32%6.73M | 91.27%7.17M | 73.17%30.71M | 227.43%16.27M | 31.57%5.96M | --4.73M | --3.75M | 14.05%17.73M | --4.97M |
| -General and administrative expense | 9.30%6.51M | 42.32%6.73M | 91.27%7.17M | 73.17%30.71M | 227.43%16.27M | 31.57%5.96M | --4.73M | --3.75M | 14.05%17.73M | --4.97M |
| Research and development costs | -31.64%27.59M | -35.23%27.54M | -33.51%26.87M | -0.99%165.53M | -0.36%42.24M | -9.87%40.35M | --42.53M | --40.41M | 4.61%167.19M | --42.39M |
| Operating profit | 26.37%-34.1M | 27.47%-34.28M | 22.93%-34.03M | -6.12%-196.24M | -23.54%-58.51M | 6.06%-46.31M | -47.26M | -44.16M | -5.45%-184.92M | -47.36M |
| Net non-operating interest income expense | ||||||||||
| Other net income (expense) | 2.34M | 2.71M | 3.12M | 951K | ||||||
| Other non- operating income (expenses) | --2.34M | --2.71M | --3.12M | --951K | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | 31.43%-31.76M | 33.21%-31.56M | 29.98%-30.92M | -5.60%-195.29M | -21.53%-57.56M | 6.06%-46.31M | -47.26M | -44.16M | -5.45%-184.92M | -47.36M |
| Income tax | 0 | 0 | 0 | 148.98%12.16M | 61.89%1.98M | 270.32%4.97M | 2.91M | 2.31M | 7,082.35%4.88M | 1.22M |
| Net income | 38.07%-31.76M | 37.08%-31.56M | 33.46%-30.92M | -9.29%-207.45M | -22.55%-59.54M | -1.25%-51.28M | -50.16M | -46.47M | -8.19%-189.81M | -48.58M |
| Net income continuous Operations | 38.07%-31.76M | 37.08%-31.56M | 33.46%-30.92M | -9.29%-207.45M | -22.55%-59.54M | -1.25%-51.28M | ---50.16M | ---46.47M | -8.19%-189.81M | ---48.58M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 38.07%-31.76M | 37.08%-31.56M | 33.46%-30.92M | -9.29%-207.45M | -22.55%-59.54M | -1.25%-51.28M | -50.16M | -46.47M | -8.19%-189.81M | -48.58M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 38.07%-31.76M | 37.08%-31.56M | 33.46%-30.92M | -9.29%-207.45M | -22.55%-59.54M | -1.25%-51.28M | -50.16M | -46.47M | -8.19%-189.81M | -48.58M |
| Basic earnings per share | 39.14%-1.87 | 38.12%-1.86 | 33.92%-1.84 | -9.29%-12.43 | -22.54%-3.5672 | -1.25%-3.0728 | -3.006 | -2.7844 | -8.19%-11.3738 | -2.9112 |
| Diluted earnings per share | 39.14%-1.87 | 38.12%-1.86 | 33.92%-1.84 | -9.29%-12.43 | -22.54%-3.5672 | -1.25%-3.0728 | -3.006 | -2.7844 | -8.19%-11.3738 | -2.9112 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data